Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01436214 | Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer | unknown | Phase 1 / Phase 2 | 60 | Adamis Pharmaceuticals CorporationINDUSTRY | 1 | Jul 16, 2015 | clinicaltrials |
| NCT02496442 | Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan | unknown | N/A | 30 | FlowmedINDUSTRY | 0 | Jul 14, 2015 | clinicaltrials |
| Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer |
| unknown |
| Phase 1 / Phase 2 |
| 75 |
| Arno TherapeuticsINDUSTRY |
| 1 |
| Jun 24, 2015 |
| clinicaltrials |
| NCT02460861 | Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical Prostatovesiculectomy(iPROLOGX) | unknown | N/A | 279 | University of MagdeburgOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT02450266 | Study Comparing MRI/Ultrasound Fusion-guided Prostate Biopsy Versus Systematic Transrectal Ultrasound-guided Biopsy(PROFUSE) | unknown | N/A | 586 | Heinrich-Heine University, DuesseldorfOTHER | 1 | May 21, 2015 | clinicaltrials |
| NCT02436122 | Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer | unknown | — | 264 | Seoul National University HospitalOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT02186925 | A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. | unknown | — | 1,000 | Meir Medical CenterOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT02375035 | Developing a Safer and More Accurate Device for Biopsies of Suspected Prostate Cancer(CAMPROBE) | unknown | — | 50 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Mar 2, 2015 | clinicaltrials |
| NCT02123888 | Simultaneous CBCT Acquisition During Arc Radiotherapy(SCART) | unknown | N/A | 75 | Sally FalkOTHER | 1 | Feb 9, 2015 | clinicaltrials |
| NCT02344667 | Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. VMAT | unknown | Phase 2 | 40 | Juravinski Cancer CenterOTHER | 0 | Jan 26, 2015 | clinicaltrials |
| NCT02123862 | Cultured Circulating Tumor Cells in Prostate and Other Cancers | unknown | — | 220 | Oscar Goodman, Jr.OTHER | 1 | Jan 19, 2015 | clinicaltrials |
| NCT02342054 | Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer(SINFRA_PROST) | unknown | Phase 2 | 49 | Hospital de CrucesOTHER | 1 | Jan 19, 2015 | clinicaltrials |
| NCT01852864 | Degarelix Before Radical Prostatectomy | unknown | Early Phase 1 | 40 | University of CambridgeOTHER | 1 | Dec 16, 2014 | clinicaltrials |
| NCT02290561 | SmartTarget THERAPY | unknown | N/A | 69 | University College, LondonOTHER | 0 | Nov 14, 2014 | clinicaltrials |
| NCT02283346 | Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial(AC-P01) | unknown | Phase 2 | 60 | AC Camargo Cancer CenterOTHER | 1 | Nov 5, 2014 | clinicaltrials |
| NCT02258087 | HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.(PROMOBRA) | unknown | Phase 2 / Phase 3 | 50 | National Institute of Oncology, HungaryOTHER | 1 | Oct 7, 2014 | clinicaltrials |
| NCT01355185 | Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences | unknown | — | 20 | AHS Cancer Control AlbertaOTHER | 1 | Oct 3, 2014 | clinicaltrials |
| NCT02233725 | MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound Guidance | unknown | Phase 1 | 50 | University of British ColumbiaOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT01842750 | The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility Study(BRAD) | unknown | N/A | 10 | The Christie NHS Foundation TrustOTHER | 1 | Jul 30, 2014 | clinicaltrials |
| NCT01726894 | Focal Therapy for Localised Prostate Cancer Using Irreversible Electroporation(Nano) | unknown | N/A | 20 | University College London HospitalsOTHER | 1 | Jun 18, 2014 | clinicaltrials |
| NCT02145494 | The SPARC Trial: Stereotactic Prostate Ablative Radiotherapy Using Cyberknife(SPARC) | unknown | Phase 2 | 20 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 23, 2014 | clinicaltrials |
| NCT02138760 | Comparison of MRI Fusion Biopsy Techniques in Men With Elevated PSA and Prior Negative Prostate Biopsy | unknown | N/A | 400 | Kaiser PermanenteOTHER | 1 | May 15, 2014 | clinicaltrials |
| NCT00452556 | The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study | unknown | Phase 2 | 86 | Nova Scotia Cancer CentreOTHER | 1 | Mar 19, 2014 | clinicaltrials |
| NCT00175396 | Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy | unknown | Phase 3 | 400 | University of British ColumbiaOTHER | 1 | Mar 17, 2014 | clinicaltrials |
| NCT02070952 | CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer | unknown | N/A | 167 | Riverside Community Hospital, CaliforniaOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00295802 | Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer | unknown | Phase 2 / Phase 3 | 141 | EDAP TMS S.A.INDUSTRY | 2 | Feb 7, 2014 | clinicaltrials |
| NCT02041559 | The Effect of Different Doses of Remifentanil on Kidney Function During Robot Assisted Prostatectomy - A Retrospective Study | unknown | — | 1,500 | Yonsei UniversityOTHER | 1 | Jan 22, 2014 | clinicaltrials |
| NCT02037464 | CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer(CAPSAICIN) | unknown | Phase 2 | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT00967954 | Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer | unknown | N/A | 120 | Cancer Research UKOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00002775 | Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 1 / Phase 2 | 37 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003633 | Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | unknown | Phase 1 | 12 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003717 | Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 2 | 17 | St. Barnabas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00024063 | SU006668 in Treating Patients With Advanced Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00045123 | R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence | unknown | Phase 2 | — | Myrexis Inc.INDUSTRY | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00684970 | Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)(TLH-202) | unknown | Phase 2 | 100 | Tiltan Pharma Ltd.INDUSTRY | 1 | Dec 5, 2013 | clinicaltrials |
| NCT01938339 | Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer | unknown | N/A | 60 | Seoul National University HospitalOTHER | 1 | Dec 5, 2013 | clinicaltrials |
| NCT00003183 | Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 1 / Phase 2 | 64 | Hope Cancer Institute, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005960 | Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | unknown | Phase 2 | — | AmgenINDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005939 | Brachytherapy in Treating Patients With Recurrent Prostate Cancer | unknown | Phase 1 / Phase 2 | — | Center for Molecular MedicineOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00348998 | Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | unknown | Phase 2 | 18 | Virginia Mason Hospital/Medical CenterOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00009750 | Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | unknown | Phase 1 | — | University of California, DavisOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00322114 | Lycopene in Preventing Prostate Cancer in Healthy Participants | unknown | N/A | 150 | University of Illinois at ChicagoOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00354497 | Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men | unknown | Phase 2 | 800 | Lawrence Livermore National Laboratory at University of CaliforniaOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00503646 | Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners | unknown | N/A | 100 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00363285 | Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer | unknown | Phase 3 | 900 | St. Bartholomew's HospitalOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00376792 | Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer | unknown | Phase 3 | 396 | Scandinavian Prostate Cancer GroupNETWORK | 5 | Aug 26, 2013 | clinicaltrials |
| NCT00553371 | Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer | unknown | — | 300 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00601406 | Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | unknown | N/A | 2,200 | The Christie NHS Foundation TrustOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00758173 | Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom | unknown | — | 2,000 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00946543 | Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer | unknown | Phase 1 | 198 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 26, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jul 16, 2015source: clinicaltrials